In concordance with previous reports, the most prevalent fusions detected in Chinese AML patients included RUNX1-RUNX1T1 (n = 82, 28.1%), KMT2A rearrangements (n = 45, 15.4%), and NUP98 rearrangements (n = 17, 5.8%). The gene discussed is RUNX1; the disease is acute myeloid leukemia.